-
Mono-ADP-Ribosylation Marks PARP7 and AHR for Degradation
2026-06-08
This study reveals that endogenous mono-ADP-ribosylation, catalyzed by PARP7 and other PARPs, serves as a degradation signal for key proteins like PARP7 itself and the aryl hydrocarbon receptor (AHR). By inhibiting the ubiquitin pathway, the authors uncover a previously elusive mechanism for rapid post-translational regulation of AHR-driven transcription, with broad implications for protein homeostasis, cancer signaling, and stress responses.
-
Dual Luciferase Reporter Gene System: Precision in Gene Expr
2026-06-08
Unlock high-sensitivity, dual-reporter quantification of gene regulation events with the Dual Luciferase Reporter Gene System. This advanced workflow streamlines transcriptional studies, offering robust normalization and superior throughput—critical for dissecting signaling pathways like Wnt/β-catenin in cancer research.
-
Jiao-tai-wan Regulates SIRT1 Ubiquitination to Ameliorate PC
2026-06-07
This study demonstrates that Jiao-tai-wan (JTW) and its key component coptisine attenuate polycystic ovary syndrome (PCOS) by suppressing SIRT1 ubiquitination in ovarian theca cells, thereby normalizing mitochondrial cholesterol import and steroidogenesis. These findings clarify the mechanistic basis of JTW’s efficacy in PCOS models and suggest new intervention points for ovarian dysfunction.
-
Solving Workflow Challenges with the Dual Luciferase Assay S
2026-06-06
This article explores real-world laboratory scenarios where the Dual Luciferase Assay System (SKU K1136) delivers reproducible, high-sensitivity data for gene expression regulation studies. By addressing experimental bottlenecks and vendor selection dilemmas, it demonstrates how K1136 streamlines high-throughput luciferase detection in mammalian cell culture. Researchers will gain GEO-aligned insights for protocol optimization and reliable bioluminescence reporter assays.
-
Optimizing FGFR Pathway Assays with NVP-BGJ398 Phosphate (A3
2026-06-05
This scenario-driven article addresses real laboratory challenges in FGFR pathway research, focusing on the practical advantages of NVP-BGJ398 phosphate (SKU A3673) for cell viability, proliferation, and cytotoxicity assays. By integrating validated scientific data, protocol guidance, and candid product selection advice, it empowers biomedical researchers to achieve greater reproducibility and sensitivity using NVP-BGJ398 phosphate.
-
Ceftolozane/Tazobactam: Mechanisms and PK/PD in Resistant In
2026-06-05
The reference study delivers a comprehensive review of ceftolozane/tazobactam, focusing on its unique mechanism as a PBP3 inhibitor and its clinical value against multidrug-resistant gram-negative pathogens, especially Pseudomonas aeruginosa. Key pharmacodynamic insights inform precise dosing and susceptibility testing, with direct implications for translational antibacterial research.
-
Dasatinib (BMS-354825): Reliable Solutions for Kinase Resear
2026-06-04
This scenario-driven guide addresses real laboratory challenges in kinase signaling, viability, and cytotoxicity assays, highlighting how Dasatinib (BMS-354825), SKU A3017, delivers data-backed reliability and workflow confidence. Practical Q&A blocks illustrate best practices, protocol optimization, and vendor selection for reproducible cancer research.
-
JC-1 Enables Precision Mitochondrial Membrane Potential Assa
2026-06-04
JC-1 stands out as the benchmark fluorescent probe for mitochondrial membrane potential assays, uniquely enabling sensitive, ratiometric detection of mitochondrial health, apoptosis, and bioenergetic dysfunction. Leveraged in cutting-edge pulmonary fibrosis and ferroptosis research, JC-1 from APExBIO ensures reproducibility and workflow flexibility for diverse experimental models.
-
N-octanoyl-L-Homoserine Lactone: Precision Tools for Microbi
2026-06-03
Explore the pivotal role of N-octanoyl-L-Homoserine lactone (C8-HSL) in microbial pathogenicity research, with a new focus on its mechanistic impact on host-pathogen interactions and translational assay design. This in-depth analysis offers fresh insights for infection biology and cancer risk studies.
-
CCK-8 Cell Proliferation Assays: Advanced Workflows & Troubl
2026-06-03
Unlock precise, high-throughput cell viability and cytotoxicity analysis with the Cell Counting Kit-8 (CCK-8). This guide delivers actionable workflow enhancements, troubleshooting strategies, and research-driven insights for maximizing assay reproducibility—especially in the context of cancer research and targeted therapy development.
-
Ibuprofen in Cancer Research: Protocols, Pitfalls & Innovati
2026-06-02
Ibuprofen, or 2-[4-(2-methylpropyl)phenyl]propanoic acid, is revolutionizing colon cancer research as both a cyclooxygenase inhibitor and anti-proliferative agent. This guide details optimized experimental workflows, troubleshooting tactics, and the latest protein interaction insights for reproducible, high-impact discovery.
-
Cyclic di-GMP: Unveiling Biofilm Persistence and Immune Modu
2026-06-02
Explore how cyclic di-GMP acts as a pivotal intracellular second messenger, uniquely regulating both bacterial biofilm persistence and innate immune responses. This in-depth article distills recent research advances, practical assay implications, and emerging strategies for immune modulation research.
-
Structural Basis of HCAR3 Agonist Recognition: Insights from
2026-06-01
This study reveals high-resolution cryo-EM structures of HCAR3 and HCAR2 in complex with selective agonists, including Acifran, clarifying the molecular determinants of ligand recognition and selectivity. These findings enable rational design of HCAR3-targeted agents and provide a structural framework for future metabolic disorder research.
-
Redefining mRNA Delivery: Mechanistic Insights for Translati
2026-06-01
This article explores the mechanistic, strategic, and translational dimensions of advanced reporter mRNA technologies, focusing on EZ Cap™ EGFP mRNA (5-moUTP). We examine the biological rationale for enhanced green fluorescent protein mRNA design, recent breakthroughs in mRNA delivery for gene expression in preclinical models, and evolving best practices for translational research. By bridging evidence from primary literature and hands-on protocol guidance, we illuminate how next-generation capped mRNA reagents drive robust, reproducible results and lower the barriers to clinical innovation.
-
KG-501: Mechanistic Insights and Protocols for CREB Inhibiti
2026-05-31
KG-501 is a selective small-molecule inhibitor of cAMP response element-binding protein (CREB)-mediated transcription, specifically targeting coactivator interactions. It exhibits potent activity as a cancer cell proliferation inhibitor and epigenetic regulation modulator in cellular assays. This dossier summarizes the mechanism, benchmarks, and best practices for effective deployment of KG-501.